Biomaterials in France Conferences – Exhibitions in 2006 Biomaterials in France Conferences – Exhibitions in 2006
•Download as PPT, PDF•
0 likes•394 views
The document summarizes two biomaterials conferences taking place in France in 2006: 1) IMPLANTS 2006 on June 21-22 in Paris, focusing on orthopedic implants and biomaterials. 2) ESB 2006 from September 27 to October 1 in Nantes, covering clinical applications of biomaterials and topics like tissue engineering. Interested companies can participate or reserve exhibition booths.
Report
Share
Report
Share
Recommended
Patents At Mach(Final)
Patents at Mach 2: Technology on the Cutting Edge. Drexel Experience in a Biomedical Engineering class focusing on Nanotechnology applications
Dr. David Mooney - Simposio Internacional 'Terapias oncológicas avanzadas'
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
13 biomaterials
The document discusses research at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab aims to address tissue damage from disease or injury by developing regenerative approaches rather than just replacement. This includes designing scaffolds, surface modifications, and cell encapsulation techniques to facilitate tissue regeneration. The goal is to shift from static tissue replacement to stimulating the body's natural healing abilities.
Application of bio implant & biomedical devices-recent advancement and bio-m...
Application of bio implant & biomedical devices-recent advancement and bio-m...Shaheed Suhrawardy Medical College
The document discusses various applications of biomaterials and biomedical devices. It covers implants for organs like eyes, ears, brain, heart, liver and kidneys. It also discusses dental and orthopedic implants, including various biomaterials used for hard and soft tissues. The document also mentions recent advancements in biomaterials, such as biodegradable materials, tissue engineering and stem cell research. Current priority research areas discussed include regenerative medicine, nano-technology and developing more biocompatible bionic devices.14 biomaterials
The document summarizes the work done at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab studies how biomaterials interact with biological systems, develops tissue engineering approaches using scaffolds and growth factors, and modifies material surfaces at the nano-scale to enhance biocompatibility. It also explores techniques like 3D printing and electrospinning to control scaffold architecture for tissue regeneration applications.
20140121_MARKET PLACE_CATALOGUE_Health
The document contains profiles of various technology offers, requests, and partner searches within the healthcare and medical industries. Some highlights include a smartphone application for psychological disorders treatment, an antimicrobial drug discovery platform, a telehealth cloud service, novel food products to prevent neurodegenerative disorders, synthetic anti-cancer drugs, and technologies related to diabetes monitoring, fetal monitoring, pain monitoring, radiation sensors, and balance/movement systems. Partners sought include companies, universities, research organizations, and those interested in licensing, testing, commercializing, or collaborating on the various healthcare technologies.
Communiqué de Presse IMCAS - PB Communication - Février 2012
This document is a press kit for the IMCAS conference to be held on January 26th, 2012 in Paris, France. It provides information about the conference organizers and directors, as well as an agenda for the international press conference that will take place at the event. Topics to be covered at the press conference include facial and neck rejuvenation trends, body shaping techniques for 2012, and using the IMCAS conference to monitor cosmetovigilance. Key speakers are named.
Genesics2 (2011) Competitive Intelligence Report
The cluster gathers yet prestigious protagonists like the CEA LIST or the CNRS LAAS, but also various innovative start-ups, recognized experts of their fields, like Gostai, Robotswin or Workfly. Even though, Aldebaran Robotics was clearly the star company in the Genesics2 forum, held in Paris on the 7th of February 2011, many promising French companies showed up and exhibited their robots to the audience. Most of these robots are a...
Recommended
Patents At Mach(Final)
Patents at Mach 2: Technology on the Cutting Edge. Drexel Experience in a Biomedical Engineering class focusing on Nanotechnology applications
Dr. David Mooney - Simposio Internacional 'Terapias oncológicas avanzadas'
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
13 biomaterials
The document discusses research at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab aims to address tissue damage from disease or injury by developing regenerative approaches rather than just replacement. This includes designing scaffolds, surface modifications, and cell encapsulation techniques to facilitate tissue regeneration. The goal is to shift from static tissue replacement to stimulating the body's natural healing abilities.
Application of bio implant & biomedical devices-recent advancement and bio-m...
Application of bio implant & biomedical devices-recent advancement and bio-m...Shaheed Suhrawardy Medical College
The document discusses various applications of biomaterials and biomedical devices. It covers implants for organs like eyes, ears, brain, heart, liver and kidneys. It also discusses dental and orthopedic implants, including various biomaterials used for hard and soft tissues. The document also mentions recent advancements in biomaterials, such as biodegradable materials, tissue engineering and stem cell research. Current priority research areas discussed include regenerative medicine, nano-technology and developing more biocompatible bionic devices.14 biomaterials
The document summarizes the work done at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab studies how biomaterials interact with biological systems, develops tissue engineering approaches using scaffolds and growth factors, and modifies material surfaces at the nano-scale to enhance biocompatibility. It also explores techniques like 3D printing and electrospinning to control scaffold architecture for tissue regeneration applications.
20140121_MARKET PLACE_CATALOGUE_Health
The document contains profiles of various technology offers, requests, and partner searches within the healthcare and medical industries. Some highlights include a smartphone application for psychological disorders treatment, an antimicrobial drug discovery platform, a telehealth cloud service, novel food products to prevent neurodegenerative disorders, synthetic anti-cancer drugs, and technologies related to diabetes monitoring, fetal monitoring, pain monitoring, radiation sensors, and balance/movement systems. Partners sought include companies, universities, research organizations, and those interested in licensing, testing, commercializing, or collaborating on the various healthcare technologies.
Communiqué de Presse IMCAS - PB Communication - Février 2012
This document is a press kit for the IMCAS conference to be held on January 26th, 2012 in Paris, France. It provides information about the conference organizers and directors, as well as an agenda for the international press conference that will take place at the event. Topics to be covered at the press conference include facial and neck rejuvenation trends, body shaping techniques for 2012, and using the IMCAS conference to monitor cosmetovigilance. Key speakers are named.
Genesics2 (2011) Competitive Intelligence Report
The cluster gathers yet prestigious protagonists like the CEA LIST or the CNRS LAAS, but also various innovative start-ups, recognized experts of their fields, like Gostai, Robotswin or Workfly. Even though, Aldebaran Robotics was clearly the star company in the Genesics2 forum, held in Paris on the 7th of February 2011, many promising French companies showed up and exhibited their robots to the audience. Most of these robots are a...
Flexible Robotic Catheters Industry meets EU Markets
Is flexible robotic technology for endovascular and cardiac arrhythmia interventions really a need nowadays?
Each investigator really interested in learning more about innovative SME and innovative products, especially in the medical device field, through the Internet will be able to find out how many open issues have been left unresolved by healthcare policies and management.
BioMEMS: Microsystems for Healthcare Applications 2016 Report by Yole Develop...
With the barrier between consumer and healthcare blurring, an increasing number of healthcare applications are using MEMS components, resulting in impressive market growth!
MAJOR TRENDS WILL PROPEL THE BIOMEMS MARKET FOR THE NEXT FIVE YEARS
Faced with an aging “baby boomer” population, healthcare is more important than ever. In-vitro diagnostics, pharmaceutical research, patient monitoring, drug delivery, and implantable devices: all of these fields are growing and system integrators need new innovative technologies to rapidly improve performance, cost and size. Enter bioMEMS: micro components such as accelerometers, pressure sensors, flow sensors, and micropumps bring improved sensing and actuating functions for all of these healthcare fields. The applications are many and the market is quite segmented. Yole Développement’s BioMEMS report provides an overview of the diverse bioMEMS components and applications, along with who is using/ providing which component for which application. As a consequence of this “applications array”, the technical requirements are extremely diverse amongst similar component families.
BioMEMS have been used for years. Some are linked to solid, mature, slow-growing industries, while others are part of booming applications that are adding new fuel to the bioMEMS market – a market that will triple from $2.7B in 2015 to $7.6B in 2021! In Yole’s BioMEMS report, this dynamic growth is forecast in dollars and in units per component, taking into account the influence of all bioMEMS applications. For example, the report highlights the transition from reusable sensors to disposable ones in certain applications, thus driving huge growth in market volume.
NovaTissue Presentation
This document summarizes a technology for tissue regeneration using a biopolymer or biopolymer/ceramic composite to assemble 3D porous structures incorporating a pre-vascular network. This technology aims to help the body heal itself faster than normal by providing a scaffold that nourishes regenerating cells. It has applications in orthopedics, veterinary dentistry, and plastic surgery. Currently, bone grafting requires over 2 million surgical procedures annually but options are limited by donor site complications, limited availability, long regeneration times, and high costs. The presented technology offers benefits over current solutions like being vascularized, shapable, and always available without rejection risks. Its marketing strategy involves workshops, trade shows, and conferences to introduce Ortho Nova
CV in English
Pablo Izquierdo Pérez has over 15 years of experience in proposal writing, project development, technical consulting, and research in biotechnology and agriculture. He has worked for consulting firms, research institutes, and the Spanish government developing proposals, technical reports, and projects in areas such as rural development, irrigation, and environmental restoration. He holds an MSc in Agronomy and has studied subjects including biotechnology, bioreactors, urban green space management, and multinational project management.
Argos SpineNews 2
Pour le compte d'une association internationale, prise en charge d'un journal, rédaction d'articles de vulgarisation scientifique, interviews, reportages photos dans les domaine de la chirurgie rachidienne et de la biomécanique.
Foodie newsletter issue #1
Issue 1 (M4), was released in June 2014. It provided information on the project objectives, the three Pilots scenario and FOODIE Consortium. The FOODIE group photograph was embedded in order to make it well-acquainted. Moreover, the details of the events attended and an outlook to the upcoming conferences were provided as well as direct links to FOODIE news and direct link to the press releases.
20140402_MARKET PLACE_CATALOGUE_Health
Market Place SEIMED/EEN: exposición de ofertas, demandas tecnológicas y búsquedas de socios para proyectos europeos.
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...
This report provides an analysis of the organ-on-chip market and technology from 2019-2024. It includes market forecasts for organ-on-chip device sales and services through 2024. It also examines the organ-on-chip ecosystem and supply chain, as well as technology trends like the types of organ models, devices, materials, and cell sources used. The report aims to help pharmaceutical, biotech, and other companies understand organ-on-chip technologies and how they can be used for drug development, disease modeling, and toxicity testing applications.
Fingerprint sensor applications and technologies – Consumer market focus - 20...
From almost zero to a multi-billion dollar market in three years!
Apple introduced the iPhone 5s in 2013, after acquiring Authentec a year earlier. Since then, fingerprint sensors have been massively adopted, and the volumes of sensors shipped into the consumer market have grown incredibly. At first, the sensors were a convenience and protection feature for unlocking phones. However, they are now shifting into a security feature for online identification and mobile payment in an increasing number of smartphones.
From 23 million units in 2013, 689 million fingerprint sensors for smartphones were sold in 2016. This is an incredible 210% compound annual growth rate (CAGR) between 2013 and 2016! The 2016-2022 timeframe will see a more reasonable, but still impressive, 19% CAGR.
Fingerprint sensing is becoming a mandatory feature on every smartphone, adding a lot of value. However such an increase in volume is always followed by strong cost pressure, and this is what has happened over the last three years. The average cost of a fingerprint sensor has decreased from around $5 in 2013 to $3 in 2016, and even less for low-end technologies. And the pressure hasn’t gone away. Current technologies have now reached maturity, and are threatened by new technologies, which need lower cost to gain momentum. This is the case for ultrasonic detection, for instance.
For more information please visit our website: http://www.i-micronews.com/reports.html
Dental Access 2019 Second Quarter
Our cover for this month's issue features Dr Sherif Kandil - CEO of KLine Aligners of Europe. Know more about how KLine is changing smiles everyday transforming the lives of patients.
International collaboration in a research institute: a bibliometric study
Presentation by Odile Bedu (INRA) at the IAALD 2010 World Congress - 26-29 April 2010, Montpellier, France
ICT Assistive Technology in Europe
This document summarizes a study on the assistive technology (AT) industry in Europe, specifically for information and communication technology (ICT) products and services. The study found that the AT ICT industry is fragmented across Europe due to different national systems and policies. This makes the market smaller for companies. It recommends establishing a new industry organization to represent AT ICT interests at the European level and help network stakeholders. The organization would focus on networking, knowledge exchange, and policy lobbying to help strengthen the European AT ICT industry.
MARKET PLACE 2015_Catalogue_Health
Market Place SEIMED/EEN: exposición de ofertas‐demandas tecnológicas y búsquedas de socios para proyectos europeos
Point-of-Need 2020 – Including PCR-Based Testing
COVID-19 is shaking up the diagnostics industry and will have both short- and long-term impact.
More information: https://www.i-micronews.com/products/point-of-need-2020-including-pcr-based-testing/
Market elements of the biopharmaceutical market and single-use technologies
Relevant marketing elements and intelligence for the understanding of the biopharmaceutical and single-use technology.
Trends in Agricultural Robots. A Comparative Agronomic Grid Based on a French...
Equipment innovation is one of the crucial levers for the improvement of economic, societal and environmental performances of agriculture. In particular, precision farming is expected to be among the 10 technologies that could change our lives. Amid the different technologies enabling a greater precision of agriculture, robotics and sensors could radically change the way of farming. Automatic machines collecting and managing data, eventually feeding a bigdata approach, could provide new tools for fine-tuning farmers’ decision making and help them in mastering the environmental footprint of agriculture. Nevertheless, what is a robot from the agricultural point of view? What are the solutions under development or on the market? How to compare them? The disruptive transformation of the agricultural machinery market requires the definition of new landmarks, especially for agronomists who are facing new opportunities and technologies. We present here the early results of a comparative overview realized by a group of students in agronomy and specializing in agricultural equipment and new technologies at UniLaSalle. The five students were asked to provide figures and a summary of the agricultural robots available in France, either on the market or upcoming. Firstly, they defined what a “robot” is. They referred to Coiffet (2007) who considers “robot” a machine for the human assistance executing a work or a physical task, either as a tool handled during the execution of the task or capable to perform the work without human intervention. Accordingly, the database includes only agricultural machines fulfilling at least two out of the three following criteria: the capability to execute a task, the operational flexibility, the self-adaptability to the working environment. Three robot classes were identified (decision, assistance or substitution) further classified in two agricultural domains and related operational subdomains: crop production (including permanent crops, horticulture, field crop and other crops) and breeding (including cattle, poultry, and pig). Out of a 4 months work, the database finally contains 98 robots from 70 enterprises, with full specifications retrieved from more than 300 websites and 7 French agricultural journals, as well as through the participation to some specialized fora. For comparison, the “Agricultural Robots” report by Tractica highlighted 149 profiles over a comparable time period. Drawing upon a solid background in agronomy, the students analysed the farming operation performed by the listed robots, with a focus on the vehicle-soil interface. Altogether, the design and development of this database can provide agronomists with an up-to-date comparative grid of the existing and upcoming agricultural robots. Identifying clear landmarks in the high pace robot landscape will enhance the agronomic evaluation and enable a clearer understanding of robot relevance for farmers.
Container Closure Integrity & Visual Inspection Regulations
2015 PDA Italy Conference, Workshop
Container Closure Integrity & Visual Inspection
Regulations, Theory, Test Methods and Applications of
CCI Innovations including Hands-On Activities
10 December,| Vigarano Pieve, Italy
Via Rondona, 33 44049 Ferrara
Ageing fit 2018
This document provides information about the AgeingFit conference on innovation in senior care. The conference included exhibits from 30 sponsors and partners, panel discussions on topics related to senior care innovation, and pitching sessions for startups. Over 700 people attended the inaugural conference in 2018, which featured 50 exhibitors from 20 countries and 40 speakers, most from international organizations. The goal of the conference is to promote innovation in healthy aging by facilitating partnerships between organizations involved in the senior care market.
CV-JV-2016
Jullian Vittenet has extensive experience in catalysis, adsorption, and materials synthesis for applications in oil and gas and water treatment. He has worked as a postdoc fellow at KAUST on light olefin and aromatics production using modified zeolites. As an R&D team leader at Arkema, he led projects on developing molecular sieves for oil and gas applications. His PhD involved synthesizing porous oxides and zeolites for treating petrochemical wastewater using catalytic ozonation. He has authored several publications and patents in these areas.
CCM International Ltd
This is an introduction about CCM's experienced projects and products till Feb, 2010, to give you a clear concept about what CCM expertise in and what CCM can help you.
NHS National Framework Agreement for Medical Locums
- The document summarizes a supplier conference for the NHS National Framework Agreement for Medical Locums. It provided an introduction and background on the framework agreement and procurement process.
- It outlined the current medical locums market size, key changes in the market, and spend by specialty and grade. It then detailed the procurement timetable and key stages including the PQQ2, ITT, evaluation, and implementation.
- It covered pre-award audits that will take place for shortlisted agencies to assess recruitment procedures. Next steps and stakeholder consultation were also discussed.
Strive Teleconf Presentation Apr11 2007
The COURAGE trial found that adding PCI to optimal medical therapy did not reduce the risk of death or heart attack compared to medical therapy alone in stable coronary artery disease patients over a median 4.6 years. PCI did provide better relief of angina. The MERLIN TIMI-36 trial found that adding ranolazine to standard therapy reduced recurrent ischemia in NSTE-ACS patients compared to placebo with no increase in safety issues. A Danish registry study reported higher rates of late stent thrombosis over 1 year with drug-eluting stents compared to bare-metal stents based on ARC definitions.
More Related Content
Similar to Biomaterials in France Conferences – Exhibitions in 2006 Biomaterials in France Conferences – Exhibitions in 2006
Flexible Robotic Catheters Industry meets EU Markets
Is flexible robotic technology for endovascular and cardiac arrhythmia interventions really a need nowadays?
Each investigator really interested in learning more about innovative SME and innovative products, especially in the medical device field, through the Internet will be able to find out how many open issues have been left unresolved by healthcare policies and management.
BioMEMS: Microsystems for Healthcare Applications 2016 Report by Yole Develop...
With the barrier between consumer and healthcare blurring, an increasing number of healthcare applications are using MEMS components, resulting in impressive market growth!
MAJOR TRENDS WILL PROPEL THE BIOMEMS MARKET FOR THE NEXT FIVE YEARS
Faced with an aging “baby boomer” population, healthcare is more important than ever. In-vitro diagnostics, pharmaceutical research, patient monitoring, drug delivery, and implantable devices: all of these fields are growing and system integrators need new innovative technologies to rapidly improve performance, cost and size. Enter bioMEMS: micro components such as accelerometers, pressure sensors, flow sensors, and micropumps bring improved sensing and actuating functions for all of these healthcare fields. The applications are many and the market is quite segmented. Yole Développement’s BioMEMS report provides an overview of the diverse bioMEMS components and applications, along with who is using/ providing which component for which application. As a consequence of this “applications array”, the technical requirements are extremely diverse amongst similar component families.
BioMEMS have been used for years. Some are linked to solid, mature, slow-growing industries, while others are part of booming applications that are adding new fuel to the bioMEMS market – a market that will triple from $2.7B in 2015 to $7.6B in 2021! In Yole’s BioMEMS report, this dynamic growth is forecast in dollars and in units per component, taking into account the influence of all bioMEMS applications. For example, the report highlights the transition from reusable sensors to disposable ones in certain applications, thus driving huge growth in market volume.
NovaTissue Presentation
This document summarizes a technology for tissue regeneration using a biopolymer or biopolymer/ceramic composite to assemble 3D porous structures incorporating a pre-vascular network. This technology aims to help the body heal itself faster than normal by providing a scaffold that nourishes regenerating cells. It has applications in orthopedics, veterinary dentistry, and plastic surgery. Currently, bone grafting requires over 2 million surgical procedures annually but options are limited by donor site complications, limited availability, long regeneration times, and high costs. The presented technology offers benefits over current solutions like being vascularized, shapable, and always available without rejection risks. Its marketing strategy involves workshops, trade shows, and conferences to introduce Ortho Nova
CV in English
Pablo Izquierdo Pérez has over 15 years of experience in proposal writing, project development, technical consulting, and research in biotechnology and agriculture. He has worked for consulting firms, research institutes, and the Spanish government developing proposals, technical reports, and projects in areas such as rural development, irrigation, and environmental restoration. He holds an MSc in Agronomy and has studied subjects including biotechnology, bioreactors, urban green space management, and multinational project management.
Argos SpineNews 2
Pour le compte d'une association internationale, prise en charge d'un journal, rédaction d'articles de vulgarisation scientifique, interviews, reportages photos dans les domaine de la chirurgie rachidienne et de la biomécanique.
Foodie newsletter issue #1
Issue 1 (M4), was released in June 2014. It provided information on the project objectives, the three Pilots scenario and FOODIE Consortium. The FOODIE group photograph was embedded in order to make it well-acquainted. Moreover, the details of the events attended and an outlook to the upcoming conferences were provided as well as direct links to FOODIE news and direct link to the press releases.
20140402_MARKET PLACE_CATALOGUE_Health
Market Place SEIMED/EEN: exposición de ofertas, demandas tecnológicas y búsquedas de socios para proyectos europeos.
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...
This report provides an analysis of the organ-on-chip market and technology from 2019-2024. It includes market forecasts for organ-on-chip device sales and services through 2024. It also examines the organ-on-chip ecosystem and supply chain, as well as technology trends like the types of organ models, devices, materials, and cell sources used. The report aims to help pharmaceutical, biotech, and other companies understand organ-on-chip technologies and how they can be used for drug development, disease modeling, and toxicity testing applications.
Fingerprint sensor applications and technologies – Consumer market focus - 20...
From almost zero to a multi-billion dollar market in three years!
Apple introduced the iPhone 5s in 2013, after acquiring Authentec a year earlier. Since then, fingerprint sensors have been massively adopted, and the volumes of sensors shipped into the consumer market have grown incredibly. At first, the sensors were a convenience and protection feature for unlocking phones. However, they are now shifting into a security feature for online identification and mobile payment in an increasing number of smartphones.
From 23 million units in 2013, 689 million fingerprint sensors for smartphones were sold in 2016. This is an incredible 210% compound annual growth rate (CAGR) between 2013 and 2016! The 2016-2022 timeframe will see a more reasonable, but still impressive, 19% CAGR.
Fingerprint sensing is becoming a mandatory feature on every smartphone, adding a lot of value. However such an increase in volume is always followed by strong cost pressure, and this is what has happened over the last three years. The average cost of a fingerprint sensor has decreased from around $5 in 2013 to $3 in 2016, and even less for low-end technologies. And the pressure hasn’t gone away. Current technologies have now reached maturity, and are threatened by new technologies, which need lower cost to gain momentum. This is the case for ultrasonic detection, for instance.
For more information please visit our website: http://www.i-micronews.com/reports.html
Dental Access 2019 Second Quarter
Our cover for this month's issue features Dr Sherif Kandil - CEO of KLine Aligners of Europe. Know more about how KLine is changing smiles everyday transforming the lives of patients.
International collaboration in a research institute: a bibliometric study
Presentation by Odile Bedu (INRA) at the IAALD 2010 World Congress - 26-29 April 2010, Montpellier, France
ICT Assistive Technology in Europe
This document summarizes a study on the assistive technology (AT) industry in Europe, specifically for information and communication technology (ICT) products and services. The study found that the AT ICT industry is fragmented across Europe due to different national systems and policies. This makes the market smaller for companies. It recommends establishing a new industry organization to represent AT ICT interests at the European level and help network stakeholders. The organization would focus on networking, knowledge exchange, and policy lobbying to help strengthen the European AT ICT industry.
MARKET PLACE 2015_Catalogue_Health
Market Place SEIMED/EEN: exposición de ofertas‐demandas tecnológicas y búsquedas de socios para proyectos europeos
Point-of-Need 2020 – Including PCR-Based Testing
COVID-19 is shaking up the diagnostics industry and will have both short- and long-term impact.
More information: https://www.i-micronews.com/products/point-of-need-2020-including-pcr-based-testing/
Market elements of the biopharmaceutical market and single-use technologies
Relevant marketing elements and intelligence for the understanding of the biopharmaceutical and single-use technology.
Trends in Agricultural Robots. A Comparative Agronomic Grid Based on a French...
Equipment innovation is one of the crucial levers for the improvement of economic, societal and environmental performances of agriculture. In particular, precision farming is expected to be among the 10 technologies that could change our lives. Amid the different technologies enabling a greater precision of agriculture, robotics and sensors could radically change the way of farming. Automatic machines collecting and managing data, eventually feeding a bigdata approach, could provide new tools for fine-tuning farmers’ decision making and help them in mastering the environmental footprint of agriculture. Nevertheless, what is a robot from the agricultural point of view? What are the solutions under development or on the market? How to compare them? The disruptive transformation of the agricultural machinery market requires the definition of new landmarks, especially for agronomists who are facing new opportunities and technologies. We present here the early results of a comparative overview realized by a group of students in agronomy and specializing in agricultural equipment and new technologies at UniLaSalle. The five students were asked to provide figures and a summary of the agricultural robots available in France, either on the market or upcoming. Firstly, they defined what a “robot” is. They referred to Coiffet (2007) who considers “robot” a machine for the human assistance executing a work or a physical task, either as a tool handled during the execution of the task or capable to perform the work without human intervention. Accordingly, the database includes only agricultural machines fulfilling at least two out of the three following criteria: the capability to execute a task, the operational flexibility, the self-adaptability to the working environment. Three robot classes were identified (decision, assistance or substitution) further classified in two agricultural domains and related operational subdomains: crop production (including permanent crops, horticulture, field crop and other crops) and breeding (including cattle, poultry, and pig). Out of a 4 months work, the database finally contains 98 robots from 70 enterprises, with full specifications retrieved from more than 300 websites and 7 French agricultural journals, as well as through the participation to some specialized fora. For comparison, the “Agricultural Robots” report by Tractica highlighted 149 profiles over a comparable time period. Drawing upon a solid background in agronomy, the students analysed the farming operation performed by the listed robots, with a focus on the vehicle-soil interface. Altogether, the design and development of this database can provide agronomists with an up-to-date comparative grid of the existing and upcoming agricultural robots. Identifying clear landmarks in the high pace robot landscape will enhance the agronomic evaluation and enable a clearer understanding of robot relevance for farmers.
Container Closure Integrity & Visual Inspection Regulations
2015 PDA Italy Conference, Workshop
Container Closure Integrity & Visual Inspection
Regulations, Theory, Test Methods and Applications of
CCI Innovations including Hands-On Activities
10 December,| Vigarano Pieve, Italy
Via Rondona, 33 44049 Ferrara
Ageing fit 2018
This document provides information about the AgeingFit conference on innovation in senior care. The conference included exhibits from 30 sponsors and partners, panel discussions on topics related to senior care innovation, and pitching sessions for startups. Over 700 people attended the inaugural conference in 2018, which featured 50 exhibitors from 20 countries and 40 speakers, most from international organizations. The goal of the conference is to promote innovation in healthy aging by facilitating partnerships between organizations involved in the senior care market.
CV-JV-2016
Jullian Vittenet has extensive experience in catalysis, adsorption, and materials synthesis for applications in oil and gas and water treatment. He has worked as a postdoc fellow at KAUST on light olefin and aromatics production using modified zeolites. As an R&D team leader at Arkema, he led projects on developing molecular sieves for oil and gas applications. His PhD involved synthesizing porous oxides and zeolites for treating petrochemical wastewater using catalytic ozonation. He has authored several publications and patents in these areas.
CCM International Ltd
This is an introduction about CCM's experienced projects and products till Feb, 2010, to give you a clear concept about what CCM expertise in and what CCM can help you.
Similar to Biomaterials in France Conferences – Exhibitions in 2006 Biomaterials in France Conferences – Exhibitions in 2006 (20)
Flexible Robotic Catheters Industry meets EU Markets
Flexible Robotic Catheters Industry meets EU Markets
BioMEMS: Microsystems for Healthcare Applications 2016 Report by Yole Develop...
BioMEMS: Microsystems for Healthcare Applications 2016 Report by Yole Develop...
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...
Fingerprint sensor applications and technologies – Consumer market focus - 20...
Fingerprint sensor applications and technologies – Consumer market focus - 20...
International collaboration in a research institute: a bibliometric study
International collaboration in a research institute: a bibliometric study
Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologies
Trends in Agricultural Robots. A Comparative Agronomic Grid Based on a French...
Trends in Agricultural Robots. A Comparative Agronomic Grid Based on a French...
Container Closure Integrity & Visual Inspection Regulations
Container Closure Integrity & Visual Inspection Regulations
More from MedicineAndHealthCancer
NHS National Framework Agreement for Medical Locums
- The document summarizes a supplier conference for the NHS National Framework Agreement for Medical Locums. It provided an introduction and background on the framework agreement and procurement process.
- It outlined the current medical locums market size, key changes in the market, and spend by specialty and grade. It then detailed the procurement timetable and key stages including the PQQ2, ITT, evaluation, and implementation.
- It covered pre-award audits that will take place for shortlisted agencies to assess recruitment procedures. Next steps and stakeholder consultation were also discussed.
Strive Teleconf Presentation Apr11 2007
The COURAGE trial found that adding PCI to optimal medical therapy did not reduce the risk of death or heart attack compared to medical therapy alone in stable coronary artery disease patients over a median 4.6 years. PCI did provide better relief of angina. The MERLIN TIMI-36 trial found that adding ranolazine to standard therapy reduced recurrent ischemia in NSTE-ACS patients compared to placebo with no increase in safety issues. A Danish registry study reported higher rates of late stent thrombosis over 1 year with drug-eluting stents compared to bare-metal stents based on ARC definitions.
alghero 2001
The document discusses EBSCO and the databases and services it provides for medical libraries and publishers. EBSCO is the largest provider of subscription management, reference databases, and online journals. It has a large collection of full-text journals and works closely with publishers to provide content and services in order to meet the information needs of medical institutions.
Strive Teleconf Presentation Apr11 2007
The COURAGE trial found that adding PCI to optimal medical therapy did not reduce the risk of death or heart attack compared to medical therapy alone in stable coronary artery disease patients over a median 4.6 years. PCI did provide better relief of angina. The MERLIN TIMI-36 trial found that adding ranolazine to standard therapy reduced recurrent ischemia in NSTE-ACS patients compared to placebo with no increase in safety issues. A Danish registry study reported higher rates of late stent thrombosis over 1 year with drug-eluting stents compared to bare-metal stents based on ARC definitions.
4 John Heimlich
The document summarizes the challenges facing the US airline industry, including rising fuel costs, lack of pricing power, heavy losses, and weak passenger revenue. It notes major carriers have cut capital expenditures and headcount significantly to reduce costs while improving productivity, but breakeven load factors remain higher than actual levels, making profitability difficult to achieve in the current environment. Fuel hedging has kept jet fuel prices below spot rates but costs are still expected to surpass 2004 record levels in 2005.
2005 Beltwide Cotton Conferences
The document summarizes new biotech and plant protection products for cotton that were recently registered or are nearing registration. It discusses 5 new biotech traits that were registered including Bollgard II, WideStrike, and LibertyLink/Ignite System. It also outlines 20 chemical products that were recently registered and 9 more that are nearing registration across different pest categories like insects, mites, weeds and diseases. The pipeline includes products with novel modes of action from major agrochemical companies.
Urrutia2
- Florida was the first state to require teacher education programs to address the needs of English language learners (ELLs) through standards-based curricula implemented at Florida Atlantic University by Dr. Gloria Artecona-Pelaez.
- There were three models developed for ESOL integration curricular models, ranging from three specialized ESOL courses to using existing courses to cover ESOL topics.
- The document discusses ESOL programs at various universities and their collaboration with school districts to improve instruction for English language learners.
Jn Iowa China Banking Slides Pwpt
China recognizes that moving toward a modern international banking system is essential for its socialist market economy. This transition presents challenges as China must balance opening its system with maintaining stability and control. China's approach has been incremental, focusing on restructuring state banks, allowing more private and foreign competition, and improving regulation according to international standards.
Ctsa Award Conference Schedule Lettersize1 16 07
The document announces a clinical and translational research conference held every Thursday afternoon from 4-5 PM at Temple University Hospital in the Erny Auditorium. The conference is supported by an NIH grant and features multidisciplinary research presentations on topics such as chronic lung disease, stem cell research, angiogenesis, and tissue factor. Contact information is provided for more details.
G2 Berman
The document discusses the China Historical GIS (CHGIS) project, which aims to create a comprehensive GIS database of historical geodata for pre-modern China. The CHGIS integrates a digital gazetteer database with GIS layers, mapping administrative divisions, places, and other features from 222 BCE to 1911 CE. It draws on diverse historical sources to record placenames, locations, administrative hierarchies, and other metadata over time. The CHGIS allows users to analyze how settlements, populations, and other variables changed and were distributed across China at different points in history.
Strive Teleconf Presentation Aug10 2005
This document summarizes a teleconference discussing the cost-effectiveness of various cardiovascular disease therapies. It provides cost-effectiveness ratios for therapies such as statins, clopidogrel, and eplerenone. It also discusses the high costs of post-MI heart failure and the benefits and cost-effectiveness of eplerenone in reducing mortality and hospitalization in MI patients with left ventricular dysfunction.
Strive Teleconf Presentation Dec6 2006
The document summarizes a teleconference discussing trials presented at the 2006 American Heart Association Scientific Sessions. It highlights the merging of two registries to form the NCDR-ACTION registry, and a national initiative to reduce door-to-balloon times for primary PCI to under 90 minutes. Trial results showed increased mortality with delays to PCI and that the advantage of PCI over fibrinolysis decreases with longer PCI-related delays.
Medical Marijuana: Health Risks and Benefits in California San
This document summarizes the health risks and benefits of medical marijuana in California from the perspective of physicians. It discusses the benefits of medical marijuana for patients in managing chronic conditions, as well as the benefits for physicians in building trust with patients and optimizing treatment. However, it also notes risks such as a lack of quality control and inconsistent dosing. It advocates for a statewide audit to fully implement California's medical marijuana law and address issues with how counties are enforcing it.
Mri Pulse Seqs
Steady-state free precession (SSFP) is a unique MRI sequence that uses both spin echo and gradient echo techniques. In SSFP, gradient echoes are acquired in each repetition time (TR) while maintaining coherence between excitations using balanced gradients. This results in a signal dependent on T1 and T2 properties. SSFP provides high signal-to-noise ratio and is used for cardiac imaging, flow imaging, T1/T2 mapping, and whole body imaging, but is sensitive to field inhomogeneities. Sensitivity encoding (SENSE) uses knowledge of multiple receiver coils' spatial sensitivities to unfold aliased signals and reduce scan time.
Strive Teleconf Presentation Sept13 2006
This document summarizes presentations given at the World Congress of Cardiology in 2006. It discusses results from the PCI ExTRACT-TIMI 25 trial showing that enoxaparin was associated with lower rates of death or heart attack compared to unfractionated heparin in patients undergoing percutaneous coronary intervention (PCI) after receiving a fibrinolytic. It also summarizes meta-analyses showing an increased risk of late stent thrombosis with drug-eluting stents compared to bare-metal stents. Faculty disclosures are provided.
webconferences.com/nihoba/2003sep17
1. Initial preclinical data suggest low risk of transgenic cells at injection site, but longer term risk is unknown. Further studies are needed to define systemic exposure and immune response risks.
2. Effects of overexpressed TGF-β include potential chondrocyte overgrowth if cells seed other joints, so this risk needs clarification. Increased infection risk also requires data from primate trials.
3. Safety of the cell preparation and administration method need validation, as injection directly into defects without guidance may fail to localize cells as intended.
www.globaloceans.org/globalconferences/2008/pdf/JSundaresan.
- The document examines the impact of sea level rise on the groundwater resources of the small, low-lying islands of Lakshdweep Archipelago in India.
- Field studies were conducted on several islands measuring coastal elevations, aquifer characteristics, and monitoring changes in groundwater levels and the freshwater-saline water interface.
- Application of Bruun's rule, which models shoreline recession under sea level rise, indicates that a 20cm rise could lead to significant shoreline erosion and contamination of fresh water resources on the islands. Vital infrastructure is also at risk of inundation.
www.gravity.psu.edu/events/conferences/inaugural/t... www.gravity.psu.edu/e...
www.gravity.psu.edu/events/conferences/inaugural/t... www.gravity.psu.edu/e...MedicineAndHealthCancer
The document summarizes the history and current state of the post-Newtonian (PN) approximation for modeling compact binary systems and gravitational waves. It discusses how PN theory has achieved an "unreasonable accuracy" in describing binary pulsars and is now being used to construct initial data and compare waveforms for numerical relativity simulations.Strive Teleconf Presentation Feb14 2007
The document summarizes an educational activity on the NCDR-ACTION Registry, which combines data from the CRUSADE and NRMI registries on the treatment of acute coronary syndromes. It describes the features and data collection process for the NCDR-ACTION Registry, including patient presentation characteristics, medical history, in-hospital treatments, outcomes, and sample institutional reports. The faculty disclosure indicates relationships with pharmaceutical companies supporting the activity.
South Africa Health Science Research
South Africa has a robust health science research sector across universities, government agencies, and private organizations. Key areas of focus include infectious diseases like HIV/AIDS, prevalent cancers, genetic disorders, and clinical trials. Major research infrastructure includes DNA sequencing facilities, biotechnology centers, and programs developing drugs from indigenous plants. South Africa has competitive advantages in health research due to high disease incidence and population diversity. Funding comes from government agencies, international partnerships, private trusts, and more.
More from MedicineAndHealthCancer (20)
NHS National Framework Agreement for Medical Locums
NHS National Framework Agreement for Medical Locums
Medical Marijuana: Health Risks and Benefits in California San
Medical Marijuana: Health Risks and Benefits in California San
www.globaloceans.org/globalconferences/2008/pdf/JSundaresan.
www.globaloceans.org/globalconferences/2008/pdf/JSundaresan.
www.gravity.psu.edu/events/conferences/inaugural/t... www.gravity.psu.edu/e...
www.gravity.psu.edu/events/conferences/inaugural/t... www.gravity.psu.edu/e...
Recently uploaded
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Skin Diseases That Happen During Summer.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort. District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PG in India
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Foundation of Yoga, YCB Level-3, Unit-1
Unit -1 of Yoga certification board, level 3, all topics covered. An exam conducted by ministry of Ayush for yoga enthusiastic students.
What are the different types of Dental implants.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Nutritional deficiency disorder in Child
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
5 Effective Homeopathic Medicines for Irregular Periods
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Helminthiasis or Worm infestation in Children for Nursing students
Brief description worm infestation/Helminthiasis for Basic B.Sc Nursing students
What is Obesity? How to overcome Obesity?
Obesity is a chronic complex disease defined by excessive fat deposits that can impair health.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Recently uploaded (20)
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Biomaterials in France Conferences – Exhibitions in 2006 Biomaterials in France Conferences – Exhibitions in 2006
- 1. Biomaterials in France Conferences – Exhibitions in 2006 Heli Pasanen-Zentz Finpro WE France Combio, Tampere April 3rd, 2006
- 2. IMPLANTS 2006 21 – 22th June, 2006 in Paris Paris, Palais des Congrès www.implants2006.com The international Conference & Exhibition dedicated to Orthopaedic Implants and Biomaterials
- 3. ESB 2006 20th European Conference on Biomaterials 27th Sept – 1st October 2006, Nantes Nantes, France (Cité des Congrès) http://www.esb2006.org TOPICS Clinical applications: Orthopaedic, Dental, Maxillofacial, Ophthalmology, Cardiovascular, Cosmetic, Cancer Artificial Organs / Biocompatibility / Biomaterials / Computer Modelling and Prototyping / Biomechanics Biomimetics / Biosensors / Drug and Gene Delivery / Implant Retrieval / Infection and Sterilisation Interfaces / Material Degradation and Failure Analysis / Nanostructures and Nanotechnology Protein Adhesion and Cell Response / Soft and Hard Tissue Regeneration and Repair Standards and Regulation / Surface Analysis and Modification / Tissue Engineering
- 4. France – Biomaterials / Events in 2006 IMPLANTS 2006 June, Paris ESB 2006 Sept/October, Nantes Company Info INTERESTED □ in confererence participation □ in exhibition booth reservation □ in other services _________________________________________ INTERESTED □ in confererence participation □ in exhibition booth reservation □ in other services _________________________________________ Company : ____________________________________ Contact Person : Mr/Ms __________________________ e-mail address : ________________________________ Tel : __________________________________________ Please forward to Mr Heikki Laurila : [email_address]
- 5. Contacts Thank You & ”Bienvenue” in France Heli Pasanen-Zentz Senior Consultant Finpro Western Europe, Paris Tel. +33 1 58 56 53 05 Mobile +33 6 03 81 44 50 Fax. +33 1 40 74 03 04 Email: [email_address]